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1. Introduction
  Atrial fibrillation (AF) is the most common arrhythmia in 
clinical, and the incidence rates are increased with age 
gradually. It can reduce the primary pump function of the 
atrium, increase ventricular burden, which can easily lead 
to heart failure, and finally increase the mortality. Currently 
the pathogenesis remains unclear, but a growing number of 
studies suggest that the occurrence and development of AF 
are closely related to inflammation. In this study, in order 
to explore the relationship between the TGF-毬1, Smad3 
and IL-6 expressions and the AF, TGF-毬1, Smad3 and 
IL-6 expression levels in patients with AF in plasma were 
detected by RT-PCR and ELISA.
  
2. Materials and methods
2.1. Clinical data
  All 50 subjects were patients with AF admitted from June 
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2008 to October 2010, including 30 males and 20 females, 
aged from 36 to 68 years old, with the average age as (49.1
暲10.6) years old. Another 30 healthy persons were selected 
during the same period as control group, including 16 
males and 14 females, aged from 37 to 62 years old, with 
the average age as (50.1暲10.1) years old. There was no 
significant difference in age (t=0.587, P=0.691) or gender 
(t=0.341, P=0.559) between two groups. In control group, 
there were 22 cases at 栺/栻 grade, and 8 cases at 栿 grade; 
while in AF group,  there were 38 cases at 栺/栻 grade, and 
12 cases at 栿 grade, with no significant difference between 
two groups (t=0.071, P=0.790). Patients with left ventricular 
ejection fraction=45% due to any other structural heart 
disease or cardiovascular disease were excluded, and 
patients with infectious or non-infectious inflammatory 
disease, acute coronary syndrome, severe liver and kidney 
dysfunction, cancer, immune system diseases, tissue 
damage within a month and vascular events, surgery and 
stroke within six months were all excluded. According to the 
criteria, the subjects were divided into paroxysmal AF group 
(13 cases) and persistent AF group (37 cases) according to 
whether they could convert to sinus rhythm spontaneously. 
They had physical examination, routine laboratory tests, 
electrocardiogram (conventional, 24 h dynamic), chest X-ray, 
thyroid function tests, and echocardiography. Transthoracic 
and/or transesophageal echocardiography examination were 
carried out to exclude potential patients with structural 
heart disease during the same time. Patients did not 
receive any angiotensin-converting enzyme inhibitors or 
drugs in angiotensin 栻 receptor blocker class within six 
months before surgery. There was no statistically significant 
difference in age, gender, body weight, and all patients have 
signed an informed consent.
2.2. Reagents
  TGF-毬1, Smad3 and IL-6 ELISA kits were all 
purchased from Shenzhen Jingmei Company. Total RNA 
extraction kits were purchased from Shanghai Sangon 
Company. TGF-毬1 (185 bp) upstream primers: 5’-
CACCCAGCCCACGAATCATCTCC-3’, downstream: 5’-
GGGCCCCCTTCTCTCTACCTG-3’; Smad3 (236 bp) upstream 
pr imers :  5 ’-GGGGATACCAGCAGCAAGAGAG-3 ’ , 
downstream: 5’-CGGCTGATGCTCCTTAAACTGT-3’; 
I L - 6  ( 1 8 2  b p )  u p s t r e a m  p r i m e r s :  5 ’ -
GGAGACGCCTTGAAGTAACTGC-3 ’ ,  downstream: 
5’-GAGTTTCCTCTGACTCCATCGCAG -3’ ;  Internal 
reference sequence GADPH (142 bp) upstream: 5’-
GCACCGTCAAGGCTGAGAAC-3’ ,  downstream: 5’-
ATGGTGGTGAAGACGCCAGT-3’, which were all synthesized 
by Shanghai Sangon Biological Engineering Co., Ltd.
2.3. Experimental methods
  5 mL fasting quiet state peripheral cubital vein blood 
were collected, and then placed in EDTA anticoagulant 
tube for 0.5 h, centrifuged at 3 000 r/min for 5 min. Upper 
layer serum was collected and stored at -80 曟, the same 
batch was detected in 2 months. TGF-毬1, Smad3 and IL-6 
protein were detected by enzyme-linked immunosorbent 
assay in accordance with the kit instructions. TGF-毬1, 
Smad3 and IL-6 mRNA was detected by detecting total RNA, 
the extraction kits were purchased from Shanghai Sangon 
Company.
2.4. Result determination
  
  Positive band at 85 bp, 236 bp, 182 bp and 142 bp were 
identified as TGF-毬1, Smad3, IL-6 and GADPH mRNA 
expression respectively; GADPH was considered as an 
internal reference, the grayscale integral value of each 
stripe were recorded by computer, statistical analysis was 
performed by sample integral value/internal reference ratio.
2.5. Statistical analysis
  All data were analyzed by SPSS 13.0 statistics software, 
t-test, variance analysis, Chi-square test and the Spearman 
rank correlation analysis were applied. P<0.05 was regarded 
as statistical significant difference.
3. Results
3.1. General information of patients in two groups
  
  In 30 patients of the control group, left ventricular 
dysfunction (LVD), left anterior descending artery (LAD), 
right anterior descending artery (RAD), left ventricular 
ejection fraction (LVEF), resting heart rate, systolic and 
diastolic blood pressure were (47.9暲4.5) mm, (55.7暲8.5) 
mm, (38.4暲4.9) mm, (63.9暲4.5)%, respectively. Resting heart 
rate (78.5暲18.6) beats/min, systolic blood pressure (127.6暲
29.0) mmHg and diastolic blood pressure (85.6暲15.2) mmHg. 
In 50 patients of the AF group , LVD, LAD, RAD, LVEF, 
resting heart rate, systolic and diastolic blood pressure 
were (50.3暲4.3) mm, (58.3暲6.6) mm, (35.9暲6.2) mm, (58.4
暲7.0)%, respectively.Resting heart rate (87.8暲15.2) beats/
min,systolic blood pressure (123.8暲38.5) mmHg and diastolic 
blood pressure (82.8暲14.0) mmHg. There were no significant 
difference in LVD (t=0.857, P=0.387), LAD  (t=0.583, P=0.724), 
RAD (t=0.526, P=0.780), LVEF (t=1.534, P=0.126), resting 
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heart rate (t=1.725, P=0.087), systolic blood pressure (t=1.367, 
P=0.179) or diastolic blood pressure  (t=0.968, P=0.356) 
between two groups . 
3.2. TGF-毬1, Smad3 and IL-6 mRNA expression
  In the persistent AF group, the TGF-毬1, Smad3 and 
IL-6 mRNA expression semi-quantitative values were 
1.5暲0.4, 1.9暲0.4 and 1.6暲0.3, respectively; while in the 
paroxysmal AF group,the values were 1.3暲0.3, 1.8暲0.4 and 
1.5暲0.3 respectively. In the control group, the TGF-毬1, 
Smad3 and IL-6 mRNA levels were 0.3暲0.1, 0.5暲0.2 and 
0.4暲0.1 respectively. TGF-毬1, Smad3 and IL-6 mRNA 
levels in the paroxysmal AF group and the persistent AF 
group were significantly higher than the control group, the 
difference was statistically significant (P<0.05). There was no 
significantly difference in TGF-毬1, Smad3 or IL-6 mRNA 
expression levels between the paroxysmal AF group and the 
persistent AF group, which was not statistically significant 
(P>0.05). 
3.3. TGF-毬1, Smad3 and IL-6 expression in protein levels
  TGF-毬1, Smad3 and IL-6 protein level semi-quantitative 
values of the persistent AF group, the paroxysmal AF group 
and the control group were shown in Table 1. TGF-毬1, 
Smad3 and IL-6 protein levels in the paroxysmal AF group 
and the persistent AF group were significantly higher than 
the control group, the difference was statistically significant 
(P<0.05). There was no significant difference in TGF-
毬1, Smad3 or IL-6 mRNA6 protein levels between the 
paroxysmal AF group and the persistent AF group, which 
was not statistically significant (P>0.05).
Table 1 
TGF-毬1, Smad3 and IL-6 expressions of patients of each group in 
protein levels. 
Groups n TGF-毬1 Smad3 IL-6
Persistent AF group 37 2.3暲0.8* 1.6暲0.3* 1.9暲0.4*
Paroxysmal AF group 13 2.1暲0.7* 1.5暲0.3* 1.8暲0.4*
Control group 30 0.5暲0.2 0.8暲0.2 0.3暲0.1
Note: Compared with normal control group * P<0.05.
3.4. Relationship of TGF-毬1, Smad3 and IL-6 mRNA level 
expressions and clinical features of patients in the persistent 
AF group
  The relationship of TGF-毬1, Smad3 and IL-6 mRNA 
expression levels in patients with persistent AF and gender, 
age, NYHA classification, LAD, LVEF, resting heart rate, 
systolic blood pressure and AF time were shown in Table 
2. TGF-毬1 mRNA expression in 曒50 years subgroup was 
significantly higher than that in the <50 years subgroups, 
and it was higher in the NYHA 栿 subgroup than in the 栺/
栻 grade subgroup, and it was also higher in the LVEF<50% 
subgroup than in LVEF曒50% group, and significantly 
higher in the AF time 曒36 months subgroup than that in 
<36 months subgroup, the differences were statistically 
significant (P<0.05). Smad3 and IL-6 expressions in the in 
the LVEF<50% subgroup were both higher that than that in 
LVEF曒50% group, and higher in the AF time 曒36 months 
subgroup than that in <36 months subgroup, the differences 
were statistically significant (P<0.05).
Table 2
Relationship of TGF-毬1, Smad3 and IL-6 mRNA level expression 
and clinical features.
Groups n TGF-毬1 Smad3 IL-6
Gender
Male 21 2.0暲0.8 1.6暲0.3 2.0暲0.4
Female 16 2.2暲0.8 1.5暲0.3 1.8暲0.3
Age (years)
曒50 21 2.3暲0.9 1.6暲0.3 1.7暲0.3
<50 16 1.8暲0.5* 1.4暲0.2 2.0暲0.4
NYHA Grade
栺/栻Grade 32 1.5暲0.4 1.3暲0.3 1.8暲0.3
III Grade   5 2.9暲1.1* 1.6暲0.2 2.2暲0.4
LAD(mm)
曒40 32 2.2暲0.8 1.4暲0.2 2.0暲0.4
<40   5 2.0暲0.8 1.6暲0.2 2.2暲0.4
LVEF(%)
曒50 27 1.7暲0.6 1.0暲0.5 1.7暲0.3
<50 10 2.3暲0.7* 1.8暲0.3* 2.5暲0.5*
Resting heart rate
曒90 11 2.3暲0.7 1.6暲0.4 1.8暲0.4
<90 26 2.0暲0.8 1.3暲0.2 1.9暲0.3
Systolic blood pressure (mmHg)
曒140 15 1.9暲0.7 1.7暲0.4 1.7暲0.4
<140 22 2.2暲0.8 1.4暲0.2 2.0暲0.4
AF time (month)
曒36 27 2.3暲0.9 1.8暲0.4 2.4暲0.6
<36 10 1.7暲0.6* 1.3暲0.2* 1.8暲0.4*
Note: Compared with the same factors in the group * P<0.05.
3. 5. Correlation analysis of TGF-毬1, Smad3 and IL-6
  In the persistent AF group, the TGF-毬1, Smad3 and IL-6 
mRNA expression were analyzed by Pearson product-
moment correlation. The result showed that there was 
positive correlation between TGF-毬1 and Smad3 (r=0.687, 
P=0.027), there was positive correlation between TGF-毬
1 and IL-6 mRNA (r=0.547, P=0.034), and there was also 
positive correlation between Smad3 and IL-6 mRNA (r= 
0.823, P=0.014).
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4. Discussion
   AF is the most common sustained arrhythmia, the overall 
incidence rate was 0.4% and the incidence of AF increased 
with age. The AF frequency can reach from 300 to 600 
beats/min, no only fast but also irregular,beats faster than 
common people and absolutely arrhythmia, the atrial lost 
their contractile function. Study in our country showed the 
AF prevalence was 0.77%, and the male prevalence of AF 
(0.9%) was higher than females (0.7%). Furthermore there is a 
close correlation of the prevalence of AF and coronary heart 
disease, hypertension and heart failure and other diseases, 
AF has become an important issue of public health[1]. 
Wijffels et al[2] first proposed the concept of atrial electrical 
remodeling, this view has become popular of the AF 
research. The “electric remodeling” and “atrial structural 
remodeling” of the AF have also been concerned in recent 
years. Atrial structural remodeling mainly presented as 
atrial fibrosis, myofibrillar dissolution, atrial muscle cell 
apoptosis. Atrial interstitial fibrosis plays an important role 
in the atrial structural remodeling process,mainly presented 
the increased collagen deposition of the interstitial, 
imbalance and disorder which lead to the inhomogeneity of 
atrial conduction, provided the pathological basis of AF[3,4].
  TGF-毬 has three subtypes, which were TGF-毬1, 2 
and 3. TGF-毬1, 2 contribute to the formation of scar 
tissue, while TGF-毬3 has the anti-scarring effect. TGF-
毬1 is an important factor to promoting fibrosis. In the 
AF development process, TGF-毬1 can promote atrial 
fibrosis, inflammation, tissue remodeling and then lead to 
tissue fibrosis[5]. Smad is an important signal transduction 
molecules of the TGF-毬downstream, different type Smad 
can mediated different signal transduction of the TGF-
毬 family members. There are reports speculated that 
Smad3 play a role in fibrosis; TGF-毬1/Smad signaling 
pathway was significant in the process of atrial fibrosis[5,6]. 
Studies have shown that there was an association between 
AF and inflammation, manifested in the maintenance of 
AF substrate, and inflammation is also involved in atrial 
structural and electrophysiological remodeling[7,8]. Recent 
studies have found that the IL-6 concentration of patients 
with AF was significantly higher.In the exclusion of other 
factors, the IL-6 levels and the intensity of the inflammatory 
response in patients with AF were positively correlated. In 
this study, TGF-毬1, Smad3 and IL-6 expression levels 
in plasma were detected by using RT-PCR and ELISA 
method in patients with AF, to study the specific regulatory 
pathways of TGF-毬1, Smad3 and IL-6 which promote 
atrial fibrosis,and further elaborate the mechanism of atrial 
structural remodeling.
  There were no statistically significant of the clinical data 
such as gender, age, NYHA Grade of patients in the AF 
group and the control group by analyzing the clinical data 
we obtained. Our results showed that in the persistent AF 
group, the paroxysmal AF group and the control group the 
expression levels of TGF-毬1 mRNA semi-quantitative 
values were 1.5暲0.4, 1.3暲0.3, 0.3暲0.1, respectively; Smad3 
mRNA the expression levels of TGF-毬1 mRNA semi-
quantitative values in the three groups were 1.9暲0.4, 1.8暲
0.4, 0.5暲0.2, respectively; IL-6 mRNA the expression levels 
of TGF-毬1 mRNA semi-quantitative values in the three 
groups were 1.6暲0.3, 1.5暲0.3, 0.4暲0.1, respectively. The 
TGF-毬1, Smad3 and IL-6 mRNA levels in the paroxysmal 
AF group and the persistent AF group were significantly 
higher than the control group. There was no significantly 
difference in TGF-毬1, Smad3 and IL-6 mRNA expression 
levels between the paroxysmal AF group and the persistent 
AF group. Detected by ELISA, the TGF-毬1, Smad3 and IL-6 
expression of the AF group (persistent and paroxysmal) were 
higher than the control group, which confirmed the increase 
of TGF-毬1, Smad3 and IL-6 were related with AF, and may 
be involved in the development of AF.
  Li[5] confirmed TGF-毬1/Smad pathways involved in atrial 
structural remodeling of the AF, which was involved in the 
occurrence and development of the AF. TGF-毬1 take part 
in the fibrosis of the liver, lung, kidney, pancreas and other 
organs, which have been extensively proven, and also plays 
an important role in the process of cardiac fibrosis[9,10]. The 
study found that TGF-毬1 expression was high in patients 
with persistent AF in the high age group (曒50 years) and 
the NYHA 栿 subgroup.The TGF-毬1, Smad3 and IL-6 
were highly expressed in the LVEF <50% and AF time 曒
36 months subgroup. The heart function declined with 
age,and the prevalence of AF were higher, which suggested 
that the formation and maintenance of AF may have some 
relevance with the high expression of TGF-毬1, Smad3 
and  IL-6. TGF-毬1/Smad signal transduction pathways 
and inflammation involved in the fibrosis of AF and atrial 
structural remodeling. TGF-毬1 have a strong chemotactic 
effect on fibroblasts and inflammatory cytokines. Smad3 
can mediate TGF-毬1 in the cytoplasm transduction by 
phosphorylation; TGF-毬1 involved in the induction of 
IL-6 high expression through the mitogen-activated protein 
kinase, induces IL-6 expression by stimulating the influx of 
calcium,and can induce IL-6 high expression by inducing 
the expression of intracellular H2O2. Pearson product-
moment correlation showed that there were a positive 
correlation between TGF-毬1 and Smad3 and IL-6 in the 
persistent AF group. Inflammation and fibrosis are two 
relatively independent processes, but may be involved in 
the structural remodeling of AF, and induced the occurrence 
of AF generation[11-14].
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 TGF-毬1/Smad signal transduction pathways and 
inflammatory reactions play an important role in the 
occurrence and developmentof AF[15-23], but the exact 
mechanism still lack of experimental support. TGF-毬
1/Smad signal transduction pathways and inflammatory 
reactions play an important role in the occurrence and 
developmentof AF, but the exact mechanism still lack 
of experimental support.With the further research,it can 
provide new ideas for the prevention and treatment of AF 
and find a new target for effective treatment.
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